Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CovidTHERAPY@HOME home monitoring and treatment pathway for acute respiratory infection including COVID-19
NL-OMON52259Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxygen and corticosteroids in coronavirus disease 2019 (COVID-19) and acute respiratory illness (ARI) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Primary feasibility endpoint. Started Nov 2021; status: completed.
02
Drugs
oxygencorticosteroids
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory illness (ARI)
Beyond the preview
Go deeper on NL-OMON52259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52259.